KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $1.2 billion.

  • Gilead Sciences' Shares Outstanding (Weighted Average) fell 16.04% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 16.04%. This contributed to the annual value of $1.2 billion for FY2024, which is 8.01% down from last year.
  • Gilead Sciences' Shares Outstanding (Weighted Average) amounted to $1.2 billion in Q3 2025, which was down 16.04% from $1.2 billion recorded in Q2 2025.
  • Over the past 5 years, Gilead Sciences' Shares Outstanding (Weighted Average) peaked at $1.3 billion during Q1 2021, and registered a low of $1.2 billion during Q3 2025.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $1.3 billion, with a median of $1.2 billion in 2023.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first changed by 0.0% in 2022, then plummeted by 55.78% in 2023.
  • Over the past 5 years, Gilead Sciences' Shares Outstanding (Weighted Average) (Quarter) stood at $1.3 billion in 2021, then dropped by 0.08% to $1.3 billion in 2022, then decreased by 0.56% to $1.2 billion in 2023, then fell by 0.08% to $1.2 billion in 2024, then dropped by 0.16% to $1.2 billion in 2025.
  • Its last three reported values are $1.2 billion in Q3 2025, $1.2 billion for Q2 2025, and $1.2 billion during Q1 2025.